X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fiercepharma.com/marketing/perrigo-pairs-opill-otc-birth-control-med-wnba-multi-year-team
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217087
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214640
https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive
https://www.globenewswire.com/news-release/2023/06/26/2694408/30925/en/Agile-Therapeutics-Announces-the-Availability-of-Twirla-to-MMCAP-Infuse-Members.html
https://endpts.com/bayer-launches-seeing-red-campaign-to-break-taboos-around-heavy-periods-for-women/
https://www.fiercepharma.com/pharma/fda-will-hear-perrigos-otc-bid-birth-control-med-opill-may
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212298
https://www.prnewswire.com/news-releases/fda-approves-medicines360s-liletta-levonorgestrel-releasing-intrauterine-system-52-mg-to-prevent-pregnancy-for-up-to-eight-years-301676741.html
https://pharmaphorum.com/news/bayer-get-eu-nod-for-extended-use-of-contraceptive-mirena/
https://www.globenewswire.com/news-release/2022/10/07/2530548/30925/en/Agile-Therapeutics-Announces-Reorganization-of-Leadership-Team.html
https://endpts.com/bayer-gets-fda-nod-to-extend-use-of-popular-contraceptive-iud-mirena/
https://www.globenewswire.com/news-release/2022/01/10/2363993/30925/en/Agile-Therapeutics-and-Afaxys-Partner-to-Expand-Access-to-Twirla-Levonorgestrel-and-Ethinyl-Estradiol-Transdermal-System.html
https://www.globenewswire.com/news-release/2021/08/20/2284071/30925/en/Agile-Therapeutics-Partners-with-Telehealth-Service-Pandia-Health-to-Increase-Women-s-Access-to-Twirla-levonorgestrel-and-ethinyl-estradiol-transdermal-system.html
https://www.business-standard.com/article/news-cm/zydus-and-bayer-announce-continuity-of-their-successful-joint-venture-121062100484_1.html
https://www.globenewswire.com/news-release/2020/12/07/2140453/0/en/Agile-Therapeutics-Announces-Nationwide-Commercial-Launch-and-Availability-of-Twirla-levonorgestrel-and-ethinyl-estradiol-Transdermal-System-a-New-Non-Daily-Non-Invasive-Contracept.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091692
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207033
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207065
https://www.globenewswire.com/news-release/2020/01/02/1965657/0/en/Agile-Therapeutics-Strengthens-Commercial-Leadership-Team.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207660
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202988
https://www.europeanpharmaceuticalreview.com/news/83166/fda-grant-generic-intravaginally-iud/
https://www.ema.europa.eu/documents/psusa/levonorgestrel-list-nationally-authorised-medicinal-products-psusa/00001856/201712_en.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-24-2018-1540357479.pdf
https://www.prnewswire.com/news-releases/fda-approves-medicines360s-snda-for-liletta-levonorgestrel-releasing-intrauterine-system-52-mg-to-prevent-pregnancy-for-up-to-five-years-300731645.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205329
https://www.prnewswire.com/news-releases/medicines360-afaxys-partner-to-expand-public-health-access-to-liletta-levonorgestrel-releasing-intrauterine-system-52-mg-300707671.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204044
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-30-2018-1527659653.pdf
https://endpts.com/agile-bristles-after-fdas-third-snub-promising-a-fight-for-its-contraceptive/
https://www.prnewswire.com/news-releases/fda-acceptance-of-medicines360s-filing-for-supplemental-new-drug-application-for-liletta-levonorgestrel-releasing-intrauterine-system-52-mg-300602473.html?tc=eml_cleartime
https://www.pharmacompass.com/pdf/news/apotex-inc-issues-recall-of-alysena-28-levonorgestrel-and-ethinyl-estradiol-tablets-1518496775.pdf
http://www.pharmatimes.com/news/uk_launch_for_bayers_five-year_contraceptive_kyleena_1221191
https://www.drugstorenews.com/pharmacy/fda-approves-avion-pharmaceuticals-balcoltra/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208612
https://www.reuters.com/article/us-agile-fda/fda-rejects-agiles-contraceptive-patch-shares-plunge-idUSKBN1EG1FO
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205131
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206053
http://www.gmp-compliance.org/gmp-news/whos-position-on-the-import-alert-for-a-chinese-api-manufacturers-products
https://www.pharmacompass.com/pdf/news/qinhuangdao-zizhu-pharmaceutical-co-ltd-on-who-public-inspection-report-1499234513.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-14-2017-1497417449.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202875
http://www.in-pharmatechnologist.com/Ingredients/US-ban-for-contraceptive-API-firm-Qinhuangdao-Zizhu-has-WHO-worried
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-19-2017-1492575710.pdf
http://www.fiercepharma.com/regulatory/fda-ban-chinese-company-leaves-who-scrambling-for-contraceptives
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206851
Market Place
Share 
